Venlafaxine in social phobia: A study in selective serotonin reuptake inhibitor non-responders

International Clinical Psychopharmacology

Volumn 14, Issue 4, 1999, Pages 239-245

  Altamura, A Carlo ^a   Pioli, R ^b   Vitto, M ^b   Mannu, R ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Avoidant personality disorder; Comorbidity; Depression; Hypersensitivity to criticism; Social phobia; SSRIs; Tolerability; Venlafaxine

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL ARTICLE; COMORBIDITY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; PERSONALITY DISORDER; PRIORITY JOURNAL; RATING SCALE; SOCIAL PHOBIA;

ADOLESCENT; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; PERSONALITY DISORDERS; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 0032794768     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199907000-00006     Document Type: Article

References (14)

1. Altamura AC, Montgomery SA, Wernicke JF (1988) Evidence for 20 mg a day of fluoxetine as the optimal dose for the treatment of depression. Br J Psychiatry 153:108-111.
2. Altamura AC, Montgomery SA (1990) Fluoxetine dose, pharmacokinetics and clinical efficacy. Rev Contemp Pharmacother 1:75-81.
3. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Association.
4. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd rev edn. Washington, DC: American Psychiatric Association.
5. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 3th edn. Washington, DC: American Psychiatric Association.
6. Davidson J, Miller R, Turnbull CD, Belya M, Strickland R (1984) An evaluation of two doses of isocarboxazid in depression. J Affect Disord 6:201-207.
7. Deltito JA, Stam M (1990) Psychopharmacology treatment of avoidant personality disorders. Compr Psychiatry 30:498-509.
8. Den Boer JA, van Vliet IM, Westenberg HGM (1995) Recent developments in the psychopharmacology of social phobia. Eur Arch Psychiatry Clin Neurosci 244:309-316.
9. Katzelnick DJ, Greist JH, Jefferson JW, Mantle JM, Kobak K, Serlin RC (1994) Sertraline in social phobia: a controlled pilot study. Paper presented at the Annual Meeting of the American Psychiatric Association, New York.
10. Kelsey JE (1995) Venlafaxine in social phobia. Psychopharmacol Bull 31:767-771.
11. Liebowitz MR, Schneicr F, Hollander E, Hatterer J, Fyer A, et al. (1992) Phenelzine versus Atenolol in Social Phobia. A controlled comparison. Arch Gen Psychiatry 49:290-300.
12. Lydiard RB (1996) Panic disorder and social phobia: possible implications of comorbid depression for drug therapy. Anxiety 2:61-70.
13. Sheehan DV, Raj BA, Trehan RR, Knapp EL (1993) Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 8:63-67.
14. van Ameringen M, Mancini C, Streiner DL (1993) Fluoxetine efficacy in social phobia. J Clin Psychiatry 54:27-32.